The Medical Imaging and Technology Alliance, an organization representing radiopharmaceutical manufacturers and product developers, called on the Trump administration to exempt components and medical imaging products from the China Section 301 tariffs, which went into effect in early July. The tariffs broadly affect the robotics and machinery industries.
Here’s what you need to know:
1. A survey cited by MITA found subjecting medical technology products and components from China to the Section 301 tariffs is estimated to cost American device makers over $138 million this year. It will affect components for CT scanners and X-ray device components the most.
2. The survey also found implementing the tariffs would cause manufacturers to invest fewer resources into research and development, reducing employment in the U.S.
3. “These tariffs on imaging products or their components will harm the American medical technology sector’s ability to stay competitive and will adversely affect the U.S. economy in ways that could compromise patient access to care,” said Patrick Hope, executive director of MITA. “Though the administration has stated it will implement an exemption process, we have not yet seen any information about how or when it will do so.”
More articles about imaging:
How full-color 3D X-rays could improve patient outcomes: 3 notes on new tech
1st hospital in Wyoming adds Mazor X for spine surgery—3 things to know
Queen of the Valley Hospital named Center of Excellence in Robotic Surgery